FMR CORP 13D and 13G filings for Rubius Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-10 09:37 am Sale |
2023-04-06 | 13G | Rubius Therapeutics, Inc. RUBY |
FMR CORP | 298,019 0.329% |
-12,078,134 (-97.59%) |
Filing |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Rubius Therapeutics, Inc. RUBY |
FMR CORP | 12,376,153 13.694% |
-1,103,713 (-8.19%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Rubius Therapeutics, Inc. RUBY |
FMR CORP | 13,479,866 14.999% |
2,101,599 (+18.47%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Rubius Therapeutics, Inc. RUBY |
FMR CORP | 11,378,267 14.060% |
2,210,975 (+24.12%) |
Filing |